Dekerk SRL
0.7 FTEDekerk reported total assets of €1.12m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026), with 0.7 full-time equivalent.
The score of Dekerk shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +3 % Total assets -23 % Headcount (avg FTE) -30 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dekerk's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 146,883 € | ||||
| Equity | 731,253 € | ||||
| Cash | 329,153 € | ||||
| EBITDA | 233,400 € | ||||
| Total assets | €1.12m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
Dekerk's financial analysis
- Solvency65.1%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dekerk
Dekerk's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0539.811.532
- VAT number
- BE0539811532
- Peppol
- Registered · 0208:0539811532 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Sep 2013
- Registered office
- 3300 Tienen
- Size
- Micro · 0.7 FTE
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Dekerk (SRL) has been based in Tienen since 2013, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 146,883 € and equity of 731,253 €; its revenue is not published. With 0.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 65.1%, above the median of its sector (44.2%).
Companies similar to Dekerk
Companies in the same business, of comparable size and area, outside its group.
- Sephabel Retail sale of pharmaceutical products Leuven · balance sheet €1.21m
- Mendeljev Retail sale of pharmaceutical products Beernem · balance sheet €1.14m
- Pharmacie Van Gelder Retail sale of pharmaceutical products Colfontaine · balance sheet €1.09m
- Reine Pharma Retail sale of pharmaceutical products Brussels · balance sheet €1.03m
- Apotheek Loksbergen Retail sale of pharmaceutical products Halen · balance sheet €1.15m
- W.A. Farma Retail sale of pharmaceutical products Kontich · balance sheet €1.09m
- Ma Ressource Santé Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet €1.17m
- Farmacie Céline Desmet Retail sale of pharmaceutical products Heuvelland · balance sheet €1.06m
Frequently asked questions about Dekerk
What is the revenue of Dekerk?
Dekerk files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dekerk?
In Belgium, the VAT number is the company number prefixed with BE: BE0539811532 for Dekerk, if the company is VAT-registered. Its company number (CBE) is 0539.811.532.
Where is the registered office of Dekerk?
According to the CBE register, the registered office of Dekerk is in 3300 Tienen.
What is the equity of Dekerk?
At the close of the 2025 financial year, the equity of Dekerk amounts to 731,253 €, a solvency of 65.1% of total assets.
How many people work at Dekerk?
0.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Dekerk?
The register lists 2 active mandates at Dekerk. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dekerk
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →